Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Aptinyx price target raised to $12 from $9 at Cantor Fitzgerald » 07:35
10/28/20
10/28
07:35
10/28/20
07:35
APTX

Aptinyx

$2.97 /

-0.01 (-0.34%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Charles Duncan raised the firm's price target on Aptinyx to $12 from $9 and keeps an Overweight rating on the shares. Duncan has enhanced conviction on a path forward for post-traumatic stress disorder for NYX-783, and the broader platform, while it also accommodates the increased number of shares outstanding that results from the company's recently completed equity raise.

ShowHide Related Items >><<
APTX Aptinyx
$2.97 /

-0.01 (-0.34%)

APTX Aptinyx
$2.97 /

-0.01 (-0.34%)

10/27/20 Piper Sandler
Aptinyx initiated with an Overweight at Piper Sandler
10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
APTX Aptinyx
$2.97 /

-0.01 (-0.34%)

  • 22
    Oct
  • 10
    Jan
APTX Aptinyx
$2.97 /

-0.01 (-0.34%)

Tuesday
Initiation
Aptinyx initiated with an Overweight at Piper Sandler » 04:45
10/27/20
10/27
04:45
10/27/20
04:45
APTX

Aptinyx

$2.97 /

-0.16 (-5.11%)

Piper Sandler analyst…

Piper Sandler analyst Christopher Raymond initiated coverage of Aptinyx with an Overweight rating and $10 price target. The stock's risk/reward "skews to the upside" as the market's skepticism is overdone on NYX-783 is overdone, Raymond tells investors in a research note. NYX-783 is the most promising agent in for post traumatic stress disorder in decades, says the analyst.

ShowHide Related Items >><<
APTX Aptinyx
$2.97 /

-0.16 (-5.11%)

APTX Aptinyx
$2.97 /

-0.16 (-5.11%)

10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
APTX Aptinyx
$2.97 /

-0.16 (-5.11%)

  • 22
    Oct
  • 10
    Jan
APTX Aptinyx
$2.97 /

-0.16 (-5.11%)

Over a week ago
On The Fly
Fly Intel: Pre-market Movers » 09:13
10/22/20
10/22
09:13
10/22/20
09:13
BCRX

BioCryst

$3.60 /

+0.085 (+2.42%)

, KO

Coca-Cola

$49.97 /

-0.27 (-0.54%)

, T

AT&T

$26.71 /

-0.06 (-0.22%)

, UNP

Union Pacific

$199.40 /

-7.37 (-3.56%)

, NOC

Northrop Grumman

$308.35 /

-0.86 (-0.28%)

, DOW

Dow Inc.

$48.56 /

-0.79 (-1.60%)

, SIRI

Sirius XM

$5.86 /

+0.055 (+0.95%)

, DGX

Quest Diagnostics

$122.84 /

-0.59 (-0.48%)

, AXTA

Axalta Coating

$25.68 /

+0.105 (+0.41%)

, TSLA

Tesla

$422.56 /

+0.59 (+0.14%)

, KMB

Kimberly-Clark

$148.27 /

-0.34 (-0.23%)

, TSCO

Tractor Supply

$149.14 /

-0.56 (-0.37%)

, AAL

American Airlines

$12.74 /

-0.06 (-0.47%)

, APTX

Aptinyx

$3.89 /

-0.41 (-9.53%)

, PTON

Peloton

$124.36 /

-7.52 (-5.70%)

Check out this morning's…

ShowHide Related Items >><<
UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSCO Tractor Supply
$149.14 /

-0.56 (-0.37%)

T AT&T
$26.71 /

-0.06 (-0.22%)

SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

PTON Peloton
$124.36 /

-7.52 (-5.70%)

NOC Northrop Grumman
$308.35 /

-0.86 (-0.28%)

KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

KMB Kimberly-Clark
$148.27 /

-0.34 (-0.23%)

DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

AXTA Axalta Coating
$25.68 /

+0.105 (+0.41%)

APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

AAL American Airlines
$12.74 /

-0.06 (-0.47%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
09/29/20 JPMorgan
BioCryst resumed with an Overweight at JPMorgan
06/26/20 JMP Securities
BioCryst price target raised to $11 from $10 at JMP Securities
06/16/20 BTIG
BioCryst initiated with a Neutral at BTIG
KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
10/12/20 Citi
PepsiCo upgraded to Buy from Neutral at Citi
09/28/20 Morgan Stanley
PepsiCo trading at good entry point ahead of earnings, says Morgan Stanley
09/03/20 Morgan Stanley
Brown-Forman price target raised to $66 from $56 at Morgan Stanley
T AT&T
$26.71 /

-0.06 (-0.22%)

10/19/20 Wolfe Research
AT&T initiated with a Peer Perform at Wolfe Research
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/05/20
Fly Intel: Top five analyst downgrades
10/05/20 KeyBanc
AT&T downgraded to Underweight from Sector Weight at KeyBanc
UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

10/16/20 Barclays
Union Pacific price target raised to $195 from $170 at Barclays
10/06/20 Susquehanna
Susquehanna sees highest returns in Eastern rails
09/24/20 Benchmark
Union Pacific price target raised to $220 from $190 at Benchmark
09/01/20 Goldman Sachs
Union Pacific price target raised to $205 from $182 at Goldman Sachs
NOC Northrop Grumman
$308.35 /

-0.86 (-0.28%)

10/13/20 Credit Suisse
Northrop Grumman price target lowered to $390 from $400 at Credit Suisse
10/06/20
Fly Intel: Top five analyst upgrades
10/06/20 RBC Capital
Northrop Grumman upgraded to Outperform from Sector Perform at RBC Capital
09/08/20 Morgan Stanley
Northrop Grumman initiated with an Overweight at Morgan Stanley
DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

10/20/20 Credit Suisse
Dow Inc. price target raised to $43 from $36 at Credit Suisse
10/06/20 Wells Fargo
Dow Inc. price target raised to $54 from $45 at Wells Fargo
09/30/20 Morgan Stanley
Morgan Stanley ups Dow, Westlake, Lyondell targets on polyethylene's resilience
09/22/20 Evercore ISI
Dow Inc. initiated with an In Line at Evercore ISI
SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

10/07/20 B. Riley Securities
Sirius should be bought with Stern deal 'potentially derisked,' says B. Riley
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
10/01/20 JPMorgan
Sirius XM pullback brings 'compelling opportunity,' says JPMorgan
DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

10/21/20 Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
10/21/20 Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
10/16/20 Baird
Baird 'pounding the table' on lab stocks after 'favorable' CMS update
10/14/20 Jefferies
Quest Diagnostics price target raised to $134 from $125 at Jefferies
AXTA Axalta Coating
$25.68 /

+0.105 (+0.41%)

10/20/20 Morgan Stanley
Axalta Coating price target raised to $27 from $23 at Morgan Stanley
10/14/20
Fly Intel: Top five analyst upgrades
10/14/20 Goldman Sachs
Axalta Coating upgraded to Conviction Buy from Buy at Goldman Sachs
10/01/20 Gordon Haskett
Nippon may have 'room on plate' for Axalta deal, says Gordon Haskett
TSLA Tesla
$422.56 /

+0.59 (+0.14%)

10/22/20 GLJ Research
GLJ keeps $40 target on Tesla, says business model not sustainable
10/22/20 RBC Capital
Tesla price target raised to $339 from $290 at RBC Capital
10/22/20 Cowen
Tesla appears to be losing share in China and Europe, says Cowen
10/22/20 Wedbush
Tesla takes 'another major step forward' as profitability ramps, says Wedbush
KMB Kimberly-Clark
$148.27 /

-0.34 (-0.23%)

10/16/20
Fly Intel: Top five analyst initiations
10/16/20
Fly Intel: Top five analyst downgrades
10/16/20 JPMorgan
Kimberly-Clark downgraded to Neutral on valuation at JPMorgan
10/16/20 Berenberg
Kimberly-Clark initiated with a Buy at Berenberg
TSCO Tractor Supply
$149.14 /

-0.56 (-0.37%)

10/22/20 Baird
Tractor Supply results robust as company re-invests forward, says Baird
10/19/20 RBC Capital
Tractor Supply price target raised to $167 from $162 at RBC Capital
10/16/20 Baird
Tractor Supply survey shows demand remains firm, says Baird
10/15/20 Wells Fargo
Tractor Supply price target raised to $170 from $165 at Wells Fargo
AAL American Airlines
$12.74 /

-0.06 (-0.47%)

10/13/20
Fly Intel: Top five analyst downgrades
10/13/20 Susquehanna
American Airlines downgraded to Negative from Neutral at Susquehanna
09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
PTON Peloton
$124.36 /

-7.52 (-5.70%)

10/21/20 Goldman Sachs
Goldman downgrades Peloton to Neutral on valuation, guidance risk
10/21/20 Goldman Sachs
Peloton downgraded to Neutral from Buy at Goldman Sachs
10/20/20 KeyBanc
Peloton price target raised to $160 from $120 at KeyBanc
10/15/20 BofA
Peloton price target raised to $150 from $116 at BofA
UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSCO Tractor Supply
$149.14 /

-0.56 (-0.37%)

T AT&T
$26.71 /

-0.06 (-0.22%)

SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

PTON Peloton
$124.36 /

-7.52 (-5.70%)

NOC Northrop Grumman
$308.35 /

-0.86 (-0.28%)

KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

KMB Kimberly-Clark
$148.27 /

-0.34 (-0.23%)

DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

AXTA Axalta Coating
$25.68 /

+0.105 (+0.41%)

APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

AAL American Airlines
$12.74 /

-0.06 (-0.47%)

  • 22
    Oct
  • 23
    Jun
  • 28
    May
  • 14
    Feb
  • 10
    Jan
  • 22
    Nov
  • 14
    Nov
UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

T AT&T
$26.71 /

-0.06 (-0.22%)

SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

PTON Peloton
$124.36 /

-7.52 (-5.70%)

KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

AAL American Airlines
$12.74 /

-0.06 (-0.47%)

UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSCO Tractor Supply
$149.14 /

-0.56 (-0.37%)

T AT&T
$26.71 /

-0.06 (-0.22%)

SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

PTON Peloton
$124.36 /

-7.52 (-5.70%)

NOC Northrop Grumman
$308.35 /

-0.86 (-0.28%)

KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

KMB Kimberly-Clark
$148.27 /

-0.34 (-0.23%)

DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

AXTA Axalta Coating
$25.68 /

+0.105 (+0.41%)

APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

AAL American Airlines
$12.74 /

-0.06 (-0.47%)

UNP Union Pacific
$199.40 /

-7.37 (-3.56%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

T AT&T
$26.71 /

-0.06 (-0.22%)

SIRI Sirius XM
$5.86 /

+0.055 (+0.95%)

PTON Peloton
$124.36 /

-7.52 (-5.70%)

KO Coca-Cola
$49.97 /

-0.27 (-0.54%)

KMB Kimberly-Clark
$148.27 /

-0.34 (-0.23%)

DOW Dow Inc.
$48.56 /

-0.79 (-1.60%)

DGX Quest Diagnostics
$122.84 /

-0.59 (-0.48%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

AXTA Axalta Coating
$25.68 /

+0.105 (+0.41%)

AAL American Airlines
$12.74 /

-0.06 (-0.47%)

Syndicate
Aptinyx 14M share Secondary priced at $3.00 » 06:18
10/22/20
10/22
06:18
10/22/20
06:18
APTX

Aptinyx

$3.89 /

-0.41 (-9.53%)

The deal size was…

The deal size was increased to 14M shares from 12M shares. SVB Leerink, Piper Sandler and Cantor Fitzgerald acted as joint book running managers for the offering.

ShowHide Related Items >><<
APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

  • 22
    Oct
  • 10
    Jan
APTX Aptinyx
$3.89 /

-0.41 (-9.53%)

On The Fly
Fly Intel: After-Hours Movers » 18:58
10/20/20
10/20
18:58
10/20/20
18:58
SNAP

Snap

$28.44 /

-0.215 (-0.75%)

, CALX

Calix

$21.12 /

-0.62 (-2.85%)

, TCS

Container Store

$10.07 /

+0.935 (+10.24%)

, USNA

Usana

$77.76 /

+0.32 (+0.41%)

, HWC

Hancock Whitney

$22.41 /

+0.81 (+3.75%)

, WDFC

WD-40

$198.01 /

+2.24 (+1.14%)

, TXN

Texas Instruments

$150.72 /

-0.09 (-0.06%)

, ASTC

Astrotech

$1.66 /

+ (+0.00%)

, OCX

OncoCyte

$1.49 /

-0.02 (-1.32%)

, NFLX

Netflix

$525.50 /

-5.16 (-0.97%)

, IRBT

iRobot

$95.85 /

+4.5 (+4.93%)

, NAVI

Navient

$9.92 /

+0.19 (+1.95%)

, IBKR

Interactive Brokers

$49.84 /

+0.53 (+1.07%)

, THC

Tenet

$28.60 /

+0.41 (+1.45%)

, REPL

Replimune Group

$42.15 /

+0.03 (+0.07%)

, CWST

Casella Waste

$60.11 /

-0.22 (-0.36%)

, APTX

Aptinyx

$4.30 /

+0.66 (+18.13%)

Check out this evening's…

ShowHide Related Items >><<
WDFC WD-40
$198.01 /

+2.24 (+1.14%)

USNA Usana
$77.76 /

+0.32 (+0.41%)

TXN Texas Instruments
$150.72 /

-0.09 (-0.06%)

THC Tenet
$28.60 /

+0.41 (+1.45%)

TCS Container Store
$10.07 /

+0.935 (+10.24%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

REPL Replimune Group
$42.15 /

+0.03 (+0.07%)

OCX OncoCyte
$1.49 /

-0.02 (-1.32%)

NFLX Netflix
$525.50 /

-5.16 (-0.97%)

NAVI Navient
$9.92 /

+0.19 (+1.95%)

IRBT iRobot
$95.85 /

+4.5 (+4.93%)

IBKR Interactive Brokers
$49.84 /

+0.53 (+1.07%)

CWST Casella Waste
$60.11 /

-0.22 (-0.36%)

CALX Calix
$21.12 /

-0.62 (-2.85%)

ASTC Astrotech
$1.66 /

+ (+0.00%)

APTX Aptinyx
$4.30 /

+0.66 (+18.13%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

10/20/20 Jefferies
Snap price target raised to $33 from $30 at Jefferies
10/19/20 MKM Partners
Snap expected to post a 'beat and in-line quarter', says MKM Partners
10/19/20 Wells Fargo
Snap price target raised to $33 from $28 at Wells Fargo
10/19/20 KeyBanc
Snap price target raised to $35 from $29 at KeyBanc
CALX Calix
$21.12 /

-0.62 (-2.85%)

10/16/20 Jefferies
Calix price target raised to $30 from $25 at Jefferies
10/14/20 Needham
Calix initiated with a Buy at Needham
07/23/20 Jefferies
Jefferies boosts Calix target to $25, says not too late to buy shares
07/23/20 Craig-Hallum
Calix price target raised to $25 from $14 at Craig-Hallum
TCS Container Store
$10.07 /

+0.935 (+10.24%)

08/04/20
Fly Intel: Top five analyst downgrades
08/04/20 Goldman Sachs
Container Store downgraded to Sell from Neutral at Goldman Sachs
USNA Usana
$77.76 /

+0.32 (+0.41%)

09/11/20 Jefferies
Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies
10/30/19 Stifel
Nu Skin upgraded to Hold on 'less bad' China expectations at Stifel
HWC Hancock Whitney
$22.41 /

+0.81 (+3.75%)

10/08/20 BofA
Texas Capital downgraded to Underperform at BofA as part of pair trade
10/08/20 BofA
Hancock Whitney upgraded to Buy at BofA as part of Texas Capital pair trade
10/08/20 BofA
Hancock Whitney upgraded to Buy from Neutral at BofA
09/15/20 DA Davidson
Hancock Whitney upgraded to Buy from Neutral at DA Davidson
WDFC WD-40
$198.01 /

+2.24 (+1.14%)

07/10/20 DA Davidson
WD-40 price target raised to $233 from $212 at DA Davidson
03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
01/07/20 DA Davidson
WD-40 downgraded to Neutral from Buy at DA Davidson
TXN Texas Instruments
$150.72 /

-0.09 (-0.06%)

10/19/20 Morgan Stanley
Microchip upgraded to Overweight at Morgan Stanley following underperformance
10/16/20 Mizuho
Texas Instruments price target raised to $165 from $127 at Mizuho
10/16/20 Oppenheimer
Texas Instruments price target raised to $170 from $150 at Oppenheimer
10/16/20 Oppenheimer
Texas Instruments price target raised to $170 from $150 at Oppenheimer
ASTC Astrotech
$1.66 /

+ (+0.00%)

OCX OncoCyte
$1.49 /

-0.02 (-1.32%)

07/01/20
Fly Intel: Top five analyst downgrades
06/30/20 Piper Sandler
OncoCyte downgraded to Neutral from Overweight at Piper Sandler
06/30/20 Piper Sandler
OncoCyte downgraded to Neutral from Overweight at Piper Sandler
06/30/20 Lake Street
OncoCyte price target lowered to $4 from $6 at Lake Street
NFLX Netflix
$525.50 /

-5.16 (-0.97%)

10/20/20 Truist
Netflix paid member adds below consensus, says Truist
10/16/20 BofA
Netflix price target raised to $670 from $575 at BofA
10/16/20 Morgan Stanley
Netflix price target raised to $630 from $600 at Morgan Stanley
10/15/20 Canaccord
Netflix price target raised to $630 from $550 at Canaccord
IRBT iRobot
$95.85 /

+4.5 (+4.93%)

10/09/20 Northland
iRobot price target raised to $95 from $90 at Northland
07/23/20 Colliers
iRobot downgraded to Neutral from Buy at Colliers
07/01/20 Citi
iRobot price target raised to $85 from $60 at Citi
06/26/20
Fly Intel: Top five analyst downgrades
NAVI Navient
$9.92 /

+0.19 (+1.95%)

10/09/20 JPMorgan
Navient price target raised to $11.50 from $9.50 at JPMorgan
06/25/20 Barclays
Navient declined unprofitable Department of Education contract, says Barclays
05/20/20 Wedbush
Navient price target lowered to $10 from $18 at Wedbush
04/09/20 Stephens
Stephens upgrades Navient to Overweight on government guarantee
IBKR Interactive Brokers
$49.84 /

+0.53 (+1.07%)

07/22/20 Compass Point
Interactive Brokers downgraded to Neutral on valuation at Compass Point
07/22/20 Piper Sandler
Interactive Brokers price target raised to $57 from $48 at Piper Sandler
07/22/20 Compass Point
Interactive Brokers downgraded to Neutral from Buy at Compass Point
06/22/20 Credit Suisse
Interactive Brokers initiated with an Outperform at Credit Suisse
THC Tenet
$28.60 /

+0.41 (+1.45%)

09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 JPMorgan
Tenet downgraded to Underweight on stalled hospital recovery JPMorgan
09/21/20 JPMorgan
Tenet downgraded to Underweight from Neutral at JPMorgan
09/04/20 RBC Capital
Tenet price target raised to $35 from $30 at RBC Capital
REPL Replimune Group
$42.15 /

+0.03 (+0.07%)

10/15/20 BMO Capital
Replimune Group price target raised to $51 from $40 at BMO Capital
10/15/20 Barclays
Replimune Group price target raised to $50 from $29 at Barclays
10/15/20 H.C. Wainwright
Replimune Group upgraded to Buy from Neutral at H.C. Wainwright
10/14/20 Roth Capital
Replimune Group price target raised to $50 from $30 at Roth Capital
CWST Casella Waste
$60.11 /

-0.22 (-0.36%)

10/15/20 Berenberg
Casella Waste initiated with a Buy at Berenberg
09/24/20 Stifel
Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth
09/24/20 Stifel
Casella Waste upgraded to Buy from Hold at Stifel
07/01/20 Jefferies
GFL Environmental initiated with a Buy at Jefferies
APTX Aptinyx
$4.30 /

+0.66 (+18.13%)

10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
WDFC WD-40
$198.01 /

+2.24 (+1.14%)

USNA Usana
$77.76 /

+0.32 (+0.41%)

TXN Texas Instruments
$150.72 /

-0.09 (-0.06%)

THC Tenet
$28.60 /

+0.41 (+1.45%)

TCS Container Store
$10.07 /

+0.935 (+10.24%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

REPL Replimune Group
$42.15 /

+0.03 (+0.07%)

OCX OncoCyte
$1.49 /

-0.02 (-1.32%)

NFLX Netflix
$525.50 /

-5.16 (-0.97%)

NAVI Navient
$9.92 /

+0.19 (+1.95%)

IRBT iRobot
$95.85 /

+4.5 (+4.93%)

IBKR Interactive Brokers
$49.84 /

+0.53 (+1.07%)

HWC Hancock Whitney
$22.41 /

+0.81 (+3.75%)

CWST Casella Waste
$60.11 /

-0.22 (-0.36%)

CALX Calix
$21.12 /

-0.62 (-2.85%)

APTX Aptinyx
$4.30 /

+0.66 (+18.13%)

  • 21
    Oct
  • 22
    Oct
  • 22
    Oct
  • 30
    Jul
  • 09
    Jun
  • 27
    Feb
  • 10
    Jan
  • 14
    Nov
TXN Texas Instruments
$150.72 /

-0.09 (-0.06%)

THC Tenet
$28.60 /

+0.41 (+1.45%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

NFLX Netflix
$525.50 /

-5.16 (-0.97%)

IBKR Interactive Brokers
$49.84 /

+0.53 (+1.07%)

WDFC WD-40
$198.01 /

+2.24 (+1.14%)

USNA Usana
$77.76 /

+0.32 (+0.41%)

THC Tenet
$28.60 /

+0.41 (+1.45%)

TCS Container Store
$10.07 /

+0.935 (+10.24%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

OCX OncoCyte
$1.49 /

-0.02 (-1.32%)

NFLX Netflix
$525.50 /

-5.16 (-0.97%)

NAVI Navient
$9.92 /

+0.19 (+1.95%)

IRBT iRobot
$95.85 /

+4.5 (+4.93%)

IBKR Interactive Brokers
$49.84 /

+0.53 (+1.07%)

CWST Casella Waste
$60.11 /

-0.22 (-0.36%)

CALX Calix
$21.12 /

-0.62 (-2.85%)

APTX Aptinyx
$4.30 /

+0.66 (+18.13%)

WDFC WD-40
$198.01 /

+2.24 (+1.14%)

TXN Texas Instruments
$150.72 /

-0.09 (-0.06%)

THC Tenet
$28.60 /

+0.41 (+1.45%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

NFLX Netflix
$525.50 /

-5.16 (-0.97%)

NAVI Navient
$9.92 /

+0.19 (+1.95%)

IRBT iRobot
$95.85 /

+4.5 (+4.93%)

Syndicate
Aptinyx announces offering of 12M shares of common stock » 16:02
10/20/20
10/20
16:02
10/20/20
16:02
APTX

Aptinyx

$4.41 /

+0.765 (+21.02%)

Aptinyx announced that it…

Aptinyx announced that it intends to offer and sell 12M shares of its common stock in an underwritten public offering. Aptinyx intends to use the net proceeds received from the offering to advance the development of its novel NMDA receptor modulators, including NYX-2925, NYX-783, and NYX-458, in development for chronic pain, PTSD, and cognitive impairment, respectively, and for working capital and other general corporate purposes. SVB Leerink, Piper Sandler and Cantor are acting as joint bookrunning managers for the offering.

ShowHide Related Items >><<
APTX Aptinyx
$4.41 /

+0.765 (+21.02%)

APTX Aptinyx
$4.41 /

+0.765 (+21.02%)

10/20/20 SVB Leerink
Aptinyx price target raised to $14 from $12 at SVB Leerink
10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
APTX Aptinyx
$4.41 /

+0.765 (+21.02%)

  • 10
    Jan
APTX Aptinyx
$4.41 /

+0.765 (+21.02%)

Recommendations
Aptinyx price target raised to $14 from $12 at SVB Leerink » 15:08
10/20/20
10/20
15:08
10/20/20
15:08
APTX

Aptinyx

$4.51 /

+0.87 (+23.90%)

SVB Leerink analyst Marc…

SVB Leerink analyst Marc Goodman raised the firm's price target on Aptinyx to $14 from $12 as he raised his view of the odds of success for NYX-783 in patients with post-traumatic stress disorder, or PTSD, after the company reported results from a first Phase 2 study of the drug. Goodman keeps an Outperform rating on Aptinyx shares.

ShowHide Related Items >><<
APTX Aptinyx
$4.51 /

+0.87 (+23.90%)

APTX Aptinyx
$4.51 /

+0.87 (+23.90%)

10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
APTX Aptinyx
$4.51 /

+0.87 (+23.90%)

  • 10
    Jan
APTX Aptinyx
$4.51 /

+0.87 (+23.90%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
10/19/20
10/19
18:53
10/19/20
18:53
CCK

Crown Holdings

$82.17 /

-1.115 (-1.34%)

, ZION

Zions Bancorp

$30.22 /

-0.92 (-2.95%)

, ELS

Equity Lifestyle

$63.05 /

-0.88 (-1.38%)

, APTX

Aptinyx

$3.64 /

-0.1 (-2.67%)

, ACOR

Acorda Therapeutics

$0.69 /

+0.0214 (+3.19%)

, IVA

Inventiva

$14.70 /

+0.41 (+2.87%)

, ATEC

Alphatec

$9.88 /

-0.23 (-2.27%)

, SPNE

SeaSpine

$14.97 /

-0.42 (-2.73%)

, HXL

Hexcel

$36.30 /

+0.73 (+2.05%)

, IBM

IBM

$125.53 /

-0.4 (-0.32%)

, PPG

PPG

$134.67 /

-2.555 (-1.86%)

, PHR

Phreesia

$32.30 /

-0.43 (-1.31%)

, BLU

Bellus Health

$2.32 /

-0.07 (-2.94%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IVA Inventiva
$14.70 /

+0.41 (+2.87%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
10/07/20 Jefferies
Crown Holdings price target raised to $90 from $82 at Jefferies
09/18/20 JPMorgan
Crown Holdings price target raised to $85 from $81 at JPMorgan
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

09/29/20 Truist
Truist raises price targets on select regional banks
07/31/20 Wolfe Research
Zions Bancorp initiated with an Underperform at Wolfe Research
07/21/20 Truist
Zions Bancorp price target lowered to $40 from $50 at SunTrust
06/30/20 Truist
SunTrust raises price targets across regional/community banks
ELS Equity Lifestyle
$63.05 /

-0.88 (-1.38%)

10/01/20 BMO Capital
Sun Communities price target raised to $165 from $160 at BMO Capital
10/01/20 Berenberg
Equity Lifestyle initiated with a Buy at Berenberg
07/22/20 Baird
Equity Lifestyle upgraded to Outperform from Neutral at Baird
03/30/20 Evercore ISI
Equity Lifestyle upgraded to Outperform from In Line at Evercore ISI
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

10/24/19 JPMorgan
JPMorgan downgrades Acorda to Underweight on disappointing Inbrija launch
10/24/19 JPMorgan
Acorda Therapeutics downgraded to Underweight from Neutral at JPMorgan
IVA Inventiva
$14.70 /

+0.41 (+2.87%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

10/19/20 Stifel
Alphatec initiated with a Buy at Stifel
10/12/20 H.C. Wainwright
Alphatec price target raised to $12 from $9 at H.C. Wainwright
10/08/20 Lake Street
Alphatec price target raised to $15 from $13 at Lake Street
10/08/20 Canaccord
Alphatec price target raised to $12 from $9 at Canaccord
SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
10/06/20 Piper Sandler
SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler
08/05/20 Piper Sandler
SeaSpine remains 'must own SMID name' at Piper Sandler
06/16/20 Cantor Fitzgerald
SeaSpine assumed with an Overweight at Cantor Fitzgerald
HXL Hexcel
$36.30 /

+0.73 (+2.05%)

10/13/20 Wells Fargo
Hexcel price target lowered to $42 from $47 at Wells Fargo
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Credit Suisse
Hexcel downgraded to Neutral from Outperform at Credit Suisse
09/25/20 Truist
Hexcel started with a Hold at Truist on commercial aero exposure
IBM IBM
$125.53 /

-0.4 (-0.32%)

10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
09/22/20 UBS
IBM assumed with a Neutral at UBS
08/17/20 JPMorgan
IBM price target raised to $148 from $135 at JPMorgan
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
PPG PPG
$134.67 /

-2.555 (-1.86%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/09/20 Deutsche Bank
PPG price target raised to $150 from $135 at Deutsche Bank
10/09/20 Citi
Westlake Chemical upgraded to Buy from Neutral at Citi
09/22/20 Evercore ISI
PPG initiated with an In Line at Evercore ISI
PHR Phreesia
$32.30 /

-0.43 (-1.31%)

09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/09/20 Piper Sandler
Phreesia price target raised to $35 from $34 at Piper Sandler
07/14/20 Citi
Phreesia initiated with a Neutral at Citi
BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

08/14/20 H.C. Wainwright
Bellus Health price target lowered to $10 from $28 at H.C. Wainwright
07/07/20 Guggenheim
Guggenheim downgrades Bellus Health to Neutral after 'disappointing' cough trial
07/07/20 Guggenheim
Bellus Health downgraded to Neutral from Buy at Guggenheim
07/06/20 Jefferies
Jefferies cuts Bellus target to $6, sees potential for 'meaningful upside'
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

ELS Equity Lifestyle
$63.05 /

-0.88 (-1.38%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

  • 21
    Oct
  • 20
    Oct
  • 14
    Oct
  • 10
    Jul
  • 10
    Jan
  • 08
    Jan
  • 13
    Dec
PPG PPG
$134.67 /

-2.555 (-1.86%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IVA Inventiva
$14.70 /

+0.41 (+2.87%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

Hot Stocks
Aptinyx spikes up 50% to $5.50 after phase 2 data on NYX783 in PTSD patients  16:48
10/19/20
10/19
16:48
10/19/20
16:48
APTX

Aptinyx

$3.64 /

-0.1 (-2.67%)

 
ShowHide Related Items >><<
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

  • 10
    Jan
Hot Stocks
Aptinyx reports statistically significant data from ph.2 study of NYX783 in PTSD » 16:46
10/19/20
10/19
16:46
10/19/20
16:46
APTX

Aptinyx

$3.64 /

-0.1 (-2.67%)

The company states:…

The company states: "Aptinyx announced positive results from the first Phase 2 study of its novel NMDA receptor modulator, NYX-783, in 153 patients with post-traumatic stress disorder, or PTSD. In the Phase 2 study, NYX-783 demonstrated statistically significant and clinically meaningful efficacy results and a favorable adverse event and tolerability profile. Based on these results, the company expects to initiate a pivotal study in 2021. The primary objective of the first-in-patient study was achieved as both dose levels studied demonstrated clinically meaningful and statistically significant improvement on the Clinician-Administered PTSD Scale for DSM-5 Arousal and Reactivity Score. This scale evaluates symptoms of PTSD such as hypervigilance, exaggerated startle response, irritability and aggression, reckless or self-destructive behaviors, and concentration and sleep disturbances. The resolution of such symptoms is highly relevant to the mechanism of action of NYX-783, which has been shown to enhance extinction learning. Clinically meaningful improvement was also observed in the CAPS-5 Total Score within just four weeks in the 50 mg dose arm, which trended toward significance. In the intention-to-treat population that completed Stage 1 at week four, 78% of subjects taking NYX-783 50 mg achieved a 30% improvement from baseline in the CAPS-5 Total Score, compared to 44% of subjects taking placebo. In the same population and time period, 50% of subjects taking NYX-783 50 mg achieved a 50% CAPS-5 Total Score improvement from baseline, compared to 26% of subjects taking placebo."

ShowHide Related Items >><<
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

  • 10
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.